Inventor
LEHMANN JUERG
US19 patents
⚠️ This page may combine multiple inventors who share the name “LEHMANN JUERG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
13 patentsUS7884101B2Feb 8, 2011
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC42 citations95
US7838525B2Nov 23, 2010
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC39 citations92
US7470699B2Dec 30, 2008
Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC41 citations92
US9126932B2Sep 8, 2015
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC17 citations91
US9108969B2Aug 18, 2015
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC6 citations84
US8362248B2Jan 29, 2013
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
ARENA PHARM INC10 citations84
US9522133B2Dec 20, 2016
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
ARENA PHARM INC9 citations83
US10272094B2Apr 30, 2019
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC1 citations73
US9676758B2Jun 13, 2017
1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto
ARENA PHARM INC3 citations66
US11395824B2Jul 26, 2022
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC0 citations62
US10624900B2Apr 21, 2020
5-HT2C receptor agonists and compositions and methods of use
ARENA PHARM INC1 citations62
US7816364B2Oct 19, 2010
GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto
ARENA PHARM INC4 citations62
US10781180B2Sep 22, 2020
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
JONES ROBERT M
4 patentsUS8580841B2Nov 12, 2013
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
JONES ROBERT M21 citations92
US8415484B2Apr 9, 2013
Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
JONES ROBERT M29 citations92
US10894787B2Jan 19, 2021
Modulators of the GPR119 receptor and the treatment of disorders related thereto
JONES ROBERT M0 citations59
US8546429B2Oct 1, 2013
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
JONES ROBERT M0 citations51